Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets., PMID:40299210
[Relapse-related candidate genes and their clinicopathological connections of diffuse large B cell lymphoma]., PMID:40159024
Cone-rod homeobox transcriptionally activates TCF7 to promote the proliferation of retinal pigment epithelial and retinoblastoma cells in vitro., PMID:39559312
Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer., PMID:39487929
Gaucher-like crystal-storing histiocytosis associated with kappa chain myeloma: A case report with next generation sequencing study., PMID:39357187
Molecular Pathogenesis of Multiple Myeloma: Clinical Implications., PMID:38199896
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results., PMID:38060199
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma., PMID:37624862
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders., PMID:36620555
Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report., PMID:36383247
Effect of resistance training on satellite cells in old mice - a transcriptome study : implications for sarcopenia., PMID:35188421
Advances in the Treatment of Hairy Cell Leukemia Variant., PMID:35178674
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target., PMID:34611509
Cyclin D3 Governs Clonal Expansion of Dark Zone Germinal Center B Cells., PMID:33207194
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis., PMID:32738175
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody., PMID:32059783
Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease., PMID:31462148
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma., PMID:30538135
TLR7, a third signal for the robust generation of spontaneous germinal center B cells in systemic lupus erythematosus., PMID:29176742
The mTOR-Bach2 Cascade Controls Cell Cycle and Class Switch Recombination during B Cell Differentiation., PMID:28993481
The miR-15 family reinforces the transition from proliferation to differentiation in pre-B cells., PMID:28705801
The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex., PMID:28628091
B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains., PMID:27750045
Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells., PMID:27571708
Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1., PMID:27440711
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas., PMID:26647218
ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway., PMID:26522721
Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma., PMID:25265432
The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma., PMID:25145835
The ataxia telangiectasia mutated and cyclin D3 proteins cooperate to help enforce TCRβ and IgH allelic exclusion., PMID:25127855
High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS., PMID:24729354
Immunolocalization of cell cycle proteins (p57, p27, cyclin D3, PCNA and Ki67) in intrauterine growth retardation (IUGR) and normal human term placentas., PMID:24252562
Pax6 is required for normal cell-cycle exit and the differentiation kinetics of retinal progenitor cells., PMID:24073291
PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development., PMID:23463102
Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression., PMID:23109711
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics., PMID:22885699
Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature., PMID:22075513
Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells., PMID:21606168
CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus., PMID:21504716
RNAi-based validation of antibodies for reverse phase protein arrays., PMID:21182776
In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms., PMID:20465575
Requirement for cyclin D3 in germinal center formation and function., PMID:20404856
Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplastic anemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood., PMID:20155453
Cyclin D3/CDK11(p58) complex involved in Schwann cells proliferation repression caused by lipopolysaccharide., PMID:20066559
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes., PMID:20062012
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context., PMID:19996118
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development., PMID:19734904
Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation., PMID:19487459
Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy., PMID:18805829
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation., PMID:18694821
For research use only. Not for human or drug use.
